Company news
Pliant Therapeutics, Inc. news in 2025
Pliant Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
December 4, 2025
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference
December 1, 2025
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
November 6, 2025
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
August 7, 2025
Pliant Therapeutics Provides Update on BEACON-IPF
June 27, 2025
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
May 21, 2025
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 8, 2025
Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations
May 1, 2025
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
April 7, 2025
Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
March 17, 2025
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
March 13, 2025
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results
March 3, 2025
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
March 3, 2025
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 12, 2025
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 6, 2025
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
January 21, 2025
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 21, 2025
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 1, 2025
Decks in 2025
- Technical Presentation (May 2025)
Technical · 13 slides · May 2025